Self-reliance displayed by the production of 70% of bulk drugs and almost the entire requirement of formulations within the country.

Low cost of production.

Low R&D costs.

Innovative Scientific Manpower.

Excellent and world-class national laboratories specialising in process development and development of cost effective technologies.

Increasing balance of trade in pharma sector.

An efficient and cost effective source for procuring generic drugs especially the drugs going off patent in the next few years.

An excellent centre for clinical trials in view of the diversity in population.